RECRUITING

Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations

Description

The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.

Conditions

Study Overview

Study Details

Study overview

The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.

Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations

Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations

Condition
Cataract
Intervention / Treatment

-

Contacts and Locations

Salt Lake City

The Eye Institute of Utah, Salt Lake City, Utah, United States, 84107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 21 years or older (Adult age)
  • * Assessed to have Cataract Grade 1 and above per LOCS III or Wisconsin Grading scale in at least one eye.
  • * Able to comprehend and sign the informed consent form.
  • * Potential postoperative best corrected distance visual acuity (BCDVA) of 0.3 logMAR or better and targeted post-op refraction to be emmetropia, based on the investigator expert medical opinion.
  • * No active ocular infection or inflammation
  • * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus)
  • * Contraindicated for pupil dilation (e.g., narrow angles, allergies) per medical judgement of the investigator.
  • * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study.

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Eye institute of Utah,

Zachary J Zavodni, MD, PRINCIPAL_INVESTIGATOR, The Eye institute of Utah

Study Record Dates

2025-02-22